SB Life Science
8
179M
6
0.38
0.25
3
- Stages of investment
- Areas of investment
Summary
In 2001 was created SB Life Science, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Redwood City.
The top activity for fund was in 2005. The higher amount of exits for fund were in 2013. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this SB Life Science performs on 14 percentage points more the average number of lead investments.
The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the SB Life Science, startups are often financed by Unilever Ventures, Maverick Ventures, CSK Venture Capital. The meaningful sponsors for the fund in investment in the same round are Unilever Ventures, Maverick Ventures, Zesiger Capital. In the next rounds fund is usually obtained by Zesiger Capital, Unilever Ventures, Sano Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Genetics, Health Care. Among the various public portfolio startups of the fund, we may underline Perlegen Sciences, Kadmus Pharmaceuticals, Optimer Pharmaceuticals
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 0
- Exits
- 3
- Rounds per year
- 0.38
- Follow on index
- 0.25
- Investments by industry
- Biotechnology (7)
- Pharmaceutical (7)
- Health Care (7)
- Genetics (3)
- Therapeutics (2) Show 3 more
- Investments by region
-
- United States (7)
- Canada (1)
- Peak activity year
- 2005
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 181M
- Group Appearance index
- 1.00
- Avg. company exit year
- 11
- Avg. multiplicator
- 3.31
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CircuLite | 23 Apr 2007 | Health Care, Hospital, Medical Device | Early Stage Venture | 5M | United States, Massachusetts, Framingham |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.